LONG TERM REAL LIFE EFFICACY OF ONABOTULINUMTOXINA FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY IN A POPULATION USING INTERMITTENT SELF-CATHETERIZATION.

被引：0
|
作者：
Joussain, C. [1 ,2 ]
Popoff, M. [3 ]
Phe, V [4 ]
Schneider, Even A. [3 ]
Falcou, L. [3 ]
Chartier-Kastler, E. [4 ]
Schurch, B. [5 ]
Denys, P. [1 ,3 ,6 ,7 ]
机构：
[1] Versailles St Quentin Univ, Inserm U1179, Med Sch Paris Ile de France Ouest, Versailles, France
[2] Paris Saclay, Paris, France
[3] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France
[4] Univ Paris 06, Pierre & Marie Curie Med Sch, Pitie Salpetriere Acad Hosp, AP HP,Dept Urol, Paris, France
[5] Univ Lausanne Hosp, Dept Clin Neurosci, Neuropsychol & Neurorehabil Serv, Lausanne, Switzerland
[6] Versailles St Quentin Univ, INSERM, U1179, Med Sch Paris Ile de France Ouest, Versailles, France
[7] Hop Raymond Poincare, Dept Phys Med & Rehabil, Garches, France
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
464
引用
收藏
页码：S422 / S424
页数：3
相关论文
共 50 条
  • [21] Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis
    Yuan, Hejia
    Cui, Yuanshan
    Wu, Jitao
    Peng, Peng
    Sun, Xujie
    Gao, Zhenli
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2017, 21 (01) : 53 - 61
  • [22] SUSTAINED IMPROVEMENTS IN URINARY INCONTINENCE AND QUALITY OF LIFE OVER LONG-TERM TREATMENT WITH ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY
    Kennelly, Michael
    Dmochowski, Roger
    Schulte-Baukloh, Heinrich
    Ethans, Karen
    Jenkins, Brenda
    Guard, Steven
    Lee, Ho-Jin
    Karsenty, Gilles
    JOURNAL OF UROLOGY, 2014, 191 (04): : E942 - E942
  • [23] POSITIVE OUTCOMES AFTER FIRST TREATMENT WITH ONABOTULINUMTOXINA PERSIST LONG-TERM WITH REPEAT TREATMENTS IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY
    Dmochowski, Roger
    Aliotta, Philip
    Blok, Bertil
    Castro-Diaz, David
    Denys, Pierre
    Ethans, Karen
    Joshi, Manher
    Magyar, Andrew
    Kennelly, Michael
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S106 - S106
  • [24] Efficacy and Safety of OnabotulinumtoxinA Therapy are Sustained Over 4 Years of Treatment in Patients With Neurogenic Detrusor Overactivity: Final Results of a Long-Term Extension Study
    Kennelly, Michael
    Dmochowski, Roger
    Schulte-Baukloh, Heinrich
    Ethans, Karen
    Del Popolo, Giulio
    Moore, Courtenay
    Jenkins, Brenda
    Guard, Steven
    Zheng, Yan
    Karsenty, Gilles
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (02) : 368 - 375
  • [25] Treatment with OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients with Incontinence Due to Neurogenic Detrusor Overactivity
    Sussman, David O.
    Patel, Vaishali
    Del Popolo, Giulio
    Lam, Wayne
    Pommerville, Peter
    NEUROLOGY, 2011, 76 (09) : A160 - A160
  • [26] Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity
    Christoph, F.
    Moschkowitsch, A.
    Kempkensteffen, C.
    Schostak, M.
    Miller, K.
    Schrader, M.
    UROLOGIA INTERNATIONALIS, 2007, 79 (01) : 55 - 59
  • [27] EFFICACY AND SAFETY OF THREE ACTIVE DOSES OF ONABOTULINUMTOXINA FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY IN CHILDREN: RESULTS OF A RANDOMIZED CONTROLLED CLINICAL TRIAL
    Austin, Paul F.
    Franco, Israel
    Dobremez, Eric
    Kroll, Pawel
    Titanji, Wilson
    Geib, Till
    Jenkins, Brenda
    Hoebeke, Piet B.
    TOXICON, 2021, 190 : S6 - S6
  • [28] Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity
    Sussman, David
    Patel, Vaishali
    Del Popolo, Giulio
    Lam, Wayne
    Globe, Denise
    Pommerville, Peter
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (03) : 242 - 249
  • [29] EFFICACY AND SAFETY OF ONABOTULINUMTOXINA 100U FOR TREATMENT OF URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY IN NONCATHETERIZING MULTIPLE SCLEROSIS PATIENTS
    Kohan, Alfred D.
    Cruz, Francisco
    Denys, Pierre
    Egerdie, Blair
    Chartier-Kastler, Emmanuel
    Magyar, Andrew
    Nicandro, J. P.
    Jenkins, Brenda
    Brucker, Benjamin M.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S152 - S153
  • [30] Positive outcomes with first onabotuinumtoxinA treatment persist long term with repeat treatments in patients with neurogenic detrusor overactivity
    Dielubanza, Elodi
    Vasavada, Sandip
    BJU INTERNATIONAL, 2017, 120 (03) : E1 - E2
12345